Tag: royalty business model

May 11, 2020

Lexaria Bioscience Confirms Closing of US$2,039,228 Private Placement

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) confirms that its private placement financing.
April 23, 2020

Lexaria Receives Notice of Allowance for New Patent and Awards Stock Options

Lexaria Bioscience (CSE:LXX) a global innovator in drug delivery platforms, has received a Notice of Allowance from the United States...
March 23, 2020

Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience has expanded the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp.
March 19, 2020

Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program

Lexaria Bioscience is commencing a program to study the benefits of Lexaria's DehydraTECHTM drug delivery platform in the fight against...
March 17, 2020

Lexaria Bioscience Announces Warrant Issuance

Lexaria Bioscience Corp. announces that on March 16, 2020 it issued share purchase warrants to one of its Canadian-based consultants.
March 5, 2020

Lexaria Provides Update on Two Licensed Clients

Lexaria Bioscience has successfully processed its first DehydraTECHTM-enabled liquid nanoemulsion for CBD beverages for one of its licensed clients.
February 13, 2020

Industry Solutions from Lexaria’s DehydraTECH(TM) Hemp and Cannabis Powders

Lexaria Bioscience Corp. announces that its DehydraTECH(TM)-enabled CBD infused powders are now available for sale across the USA.